Through combining basic pre-clinical and clinical research, network analysis and computational modeling, RESOLVE aims at resolving the disturbed dynamics and mechanisms underlying the high triglyceride and low HDL cholesterol phenotype and insulin resistance in patients with the metabolic syndrome and its associated co-morbidities like cardiovascular disease, type 2 diabetes, and fatty liver disease.
RESOLVE is funded by the FP7-Health Systems Medicine call in 2012 (FP7- HEALTH n°305707).
Contact
Natal van Riel
N.A.W.v.Riel@tue.nl